Overview

An overview of tenofovir and renal disease for the HIV-treating clinician

Willem D.F. Venter, June Fabian, Charles Feldman
Southern African Journal of HIV Medicine | Vol 19, No 1 | a817 | DOI: https://doi.org/10.4102/sajhivmed.v19i1.817 | © 2018 Willem D.F. Venter, June Fabian, Charles Feldman | This work is licensed under CC Attribution 4.0
Submitted: 06 November 2017 | Published: 17 July 2018

About the author(s)

Willem D.F. Venter, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, South Africa
June Fabian, Wits Donald Gordon Medical Centre, South Africa; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Charles Feldman, Wits Donald Gordon Medical Centre, South Africa; Charlotte Maxeke Johannesburg Academic Hospital, South Africa

Abstract

Tenofovir disoproxil fumarate (TDF, commonly termed ‘tenofovir’) is the antiretroviral most commonly implicated in antiretroviral-induced nephrotoxicity. As patients on successful antiretroviral therapy (ART) age, their risk for developing renal disease may increase in part because of ART itself, but more importantly, because of HIV-associated and non-HIV-associated comorbidity. Therefore, clinicians need an approach to managing renal disease in people on TDF. TDF as a cause of acute kidney injury (AKI) or chronic kidney disease (CKD) is uncommon, and clinicians should actively exclude other causes (Box 1). In TDF-associated AKI, TDF should be interrupted in all cases, and replaced, or ART interrupted altogether. Tenofovir disoproxil fumarate toxicity can present as AKI or CKD, and as a full or partial Fanconi’s syndrome. TDF has a small but definite negative impact on kidney function (up to a 10% decrease in glomerular filtration rate [GFR]). This occurs because of altered tubular function in those exposed to TDF for treatment and as pre-exposure prophylaxis. Renal function should be assessed using creatinine-based estimated GFR at the time of initiation of TDF, if ART is changed, at 1–3 months, and then ideally every 6–12 months if stable. Specific tests of tubular function are not routinely recommended; in the case of clinical concern, a spot protein or albumin: creatinine ratio is preferable, but in resource-limited settings, urine dipstick can be used. More frequent monitoring may be required in those with established CKD (estimated glomerular filtration rate [eGFR] < 50 mL/min/1.73 m2) or risk factors for kidney disease. The most common risk factors are comorbid hypertension, diabetes, HIV-associated kidney disease, hepatitis B or C co-infection, and TDF in combination with a ritonavir-boosted protease inhibitor. Management of these comorbid conditions must be prioritised in this group. If baseline screening eGFR is < 50 mL/min/1.73 m2, abacavir (the preferred option), and dose-adjusted TDF (useful if concomitant hepatitis B), zidovudine or stavudine (d4T) remain alternatives to full-dose TDF. If there is a rapid decline in kidney function (eGFR drops by more than 25% and decreases to < 50 mL/min/1.73 m2 from of baseline function), or there is new onset or worsening of proteinuria or albuminuria, clinicians should review ART and other potentially nephrotoxic medications and comorbidity and conduct further testing if indicated. If kidney function does not improve after addressing reversible causes of renal failure, then referral to a nephrologist is appropriate. In the case of severe CKD, timeous referral for planning for renal replacement therapy is recommended. Tenofovir alafenamide, a prodrug of tenofovir, appears to have less renal toxicity and is likely to replace TDF in future.

Keywords

tenofovir; toxicity; renal

Metrics

Total abstract views: 9083
Total article views: 28337

 

Crossref Citations

1. Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa
Rephaim Mpofu, Aida N. Kawuma, Roeland E. Wasmann, Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Mandisa Sokhela, Michelle Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A. Post, David W. Haas, Gary Maartens, Phumla Sinxadi
British Journal of Clinical Pharmacology  vol: 90  issue: 5  first page: 1247  year: 2024  
doi: 10.1111/bcp.16009

2. Higher Comorbidity Burden Predicts Worsening Neurocognitive Trajectories in People with Human Immunodeficiency Virus
Ronald J Ellis, Emily Paolillo, Rowan Saloner, Robert K Heaton
Clinical Infectious Diseases  vol: 74  issue: 8  first page: 1323  year: 2022  
doi: 10.1093/cid/ciab655

3. Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Jeremy Nel, Sipho Dlamini, Graeme Meintjes, Rosie Burton, John M. Black, Natasha E.C.G. Davies, Eric Hefer, Gary Maartens, Phetho M. Mangena, Moeketsi T. Mathe, Mahomed-Yunus Moosa, Muhangwi B. Mulaudzi, Michelle Moorhouse, Jennifer Nash, Thandeka C. Nkonyane, Wolfgang Preiser, Mohammed S. Rassool, David Stead, Helen van der Plas, Cloete van Vuuren, Willem D.F. Venter, Joana F. Woods
Southern African Journal of HIV Medicine  vol: 21  issue: 1  year: 2020  
doi: 10.4102/sajhivmed.v21i1.1115

4. Tenofovir induced Fanconi syndrome in a middle age African female from Kenya, East Africa: Case report and brief literature review
Fredrick Odhiambo, Shallot Nareeba, Grace Mwangeka, Ann Njambi, Vashti Nyakebati
Clinical Case Reports  vol: 12  issue: 6  year: 2024  
doi: 10.1002/ccr3.8889

5. Drug–drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date
Camden Ellis, Keita Inaba, Christine Van de Vuurst, Atheel Ghrayeb, Theodore James Cory
Expert Opinion on Drug Metabolism & Toxicology  vol: 19  issue: 11  first page: 795  year: 2023  
doi: 10.1080/17425255.2023.2267970

6. A case of fatal acute kidney failure and anion gap metabolic acidosis in human immunodeficiency virus patient receiving tenofovir disoproxil fumarate
Nata Pratama Hardjo Lugito, Margaret Merlyn Tjiang, Jeremia Immanuel Siregar, Raoulian Irfon, Andhica Saputri
Heliyon  vol: 12  issue: 6  first page: e44824  year: 2026  
doi: 10.1016/j.heliyon.2026.e44824

7. Raman-based metabonomics unravels metabolic changes related to a first-line tenofovir-based treatment in a small cohort of South African HIV-infected patients
Zikhona Gabazana, Lungile Sitole
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  vol: 248  first page: 119256  year: 2021  
doi: 10.1016/j.saa.2020.119256

8. Cancer in children living with HIV: challenges and perspectives in the antiretroviral therapy era
Elena Chiappini, Andrea Costantino, Daniela Masci, Maria Raffaella Petrara, Luisa Galli, Anita De Rossi
World Journal of Pediatrics  vol: 21  issue: 12  first page: 1184  year: 2025  
doi: 10.1007/s12519-025-00971-x

9. Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study
Rachawit Setpakdee, Sasisopin Kiertiburanakul
Journal of Infection and Public Health  vol: 18  issue: 2  first page: 102630  year: 2025  
doi: 10.1016/j.jiph.2024.102630

10. The Prevalence and Predictors of Hypertension and Albuminuria in People with HIV (PWHIV)—Real-World Greek Data
Vasileios Petrakis, Andreas G. Tsantes, Petros Rafailidis, Konstantia Kantartzi, Maria Panopoulou, Theocharis Konstantinidis, Nikoleta Babaka, Pelagia Kriki, Stylianos Panagoutsos, Dimitrios Papazoglou, Periklis Panagopoulos
Life  vol: 15  issue: 11  first page: 1747  year: 2025  
doi: 10.3390/life15111747

11. Influence of HIV infection on cognition and overall intelligence in HIV-infected individuals: advances and perspectives
Silvere D. Zaongo, Vijay Harypursat, Farooq Rashid, Désiré Lucien Dahourou, Abdoul-Salam Ouedraogo, Yaokai Chen
Frontiers in Behavioral Neuroscience  vol: 17  year: 2023  
doi: 10.3389/fnbeh.2023.1261784

12. Magnitude of Hyperuricemia and Its Associated Factors Among People Living with Human Immunodeficiency Virus Who Enrolled in First-Line Antiretroviral Therapy in Amhara Region, Ethiopia
Mohammed Jemal, Desalegn Abebaw, Tabarak Malik, Muluken Getinet Mekuriaw, Dagmawi Abiy Abate, Temechew Munaw Abebe, Tilahun Bitew, Enatnesh Essa Osman, Adane Adugna
Journal of the International Association of Providers of AIDS Care (JIAPAC)  vol: 24  year: 2025  
doi: 10.1177/23259582251400988

13. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults
Roger Chou, Ian Blazina, Christina Bougatsos, Rebecca Holmes, Shelley Selph, Sara Grusing, Janice Jou
JAMA  vol: 324  issue: 23  first page: 2423  year: 2020  
doi: 10.1001/jama.2020.19750

14. P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target
Silvere D. Zaongo, Yanqiu Liu, Vijay Harypursat, Fangzhou Song, Huan Xia, Ping Ma, Yaokai Chen
Frontiers in Immunology  vol: 12  year: 2021  
doi: 10.3389/fimmu.2021.710121

15. Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability
Lukas Weimann, Guido Schäfer, Hanna Matthews, Maria Florey, Robin Scheiter, Anja Hüfner, Sabine Jordan, Marc Grenz, Stefan Schmiedel, Julian Schulze zur Wiesch, Olaf Degen, Till Koch
JAIDS Journal of Acquired Immune Deficiency Syndromes  vol: 93  issue: 1  first page: e1  year: 2023  
doi: 10.1097/QAI.0000000000003170

16. Management of Hepatitis B in Pregnancy
Jeanette Rios, Lital Aliasi-Sinai, Natalia Schmidt, Tatyana Kushner
Current Hepatology Reports  vol: 23  issue: 2  first page: 278  year: 2024  
doi: 10.1007/s11901-024-00659-2

17. Impact of Antiretroviral Therapy on Kidney Disease in HIV Infected Individuals – A Qualitative Systematic Review
Harsha Adnani, Nirav Agrawal, Akshay Khatri, Jaclyn Vialet, Meng Zhang, Joseph Cervia
Journal of the International Association of Providers of AIDS Care (JIAPAC)  vol: 21  year: 2022  
doi: 10.1177/23259582221089194

18. A review on synthesis of antiviral drugs, in silico studies and their toxicity
Sanchit Ratra, Bhaskaranand Pant, Kapil Roy, Sunny Manohar, Pradeep Kumar, Sangeeta Singh, Kaniki Tumba, Kamlesh Kumari, Prashant Singh
Journal of the Indian Chemical Society  vol: 100  issue: 3  first page: 100936  year: 2023  
doi: 10.1016/j.jics.2023.100936

19. Prevalence of kidney injury in patients taking tenofovir based antiretroviral therapy at a primary health care clinic, in East Rand,Gauteng Province
P Makamu, S Bezuidenhout, M Matlala
Hospital Practice  vol: 49  issue: 2  first page: 88  year: 2021  
doi: 10.1080/21548331.2020.1843320

20. Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure
Silvere D. Zaongo, Yue Wang, Ping Ma, Fang-Zhou Song, Yao-Kai Chen
Chinese Medical Journal  vol: 134  issue: 23  first page: 2776  year: 2021  
doi: 10.1097/CM9.0000000000001797

21. PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention
Kenneth H. Mayer, Lao-Tzu Allan-Blitz
JAIDS Journal of Acquired Immune Deficiency Syndromes  vol: 82  issue: 2  first page: S113  year: 2019  
doi: 10.1097/QAI.0000000000002169

22. Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications
F. Kalemeera, B. Godman, A. Stergachis, T. Rennie
Hospital Practice  vol: 48  issue: 1  first page: 35  year: 2020  
doi: 10.1080/21548331.2020.1703438

23. Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia
Francis Kalemeera, Brian Godman, Andy Stergachis, Timothy Rennie
Pharmacoepidemiology and Drug Safety  vol: 30  issue: 2  first page: 189  year: 2021  
doi: 10.1002/pds.5125

24. Tenofovir-Induced Renal Dysfunction Among HIV-Infected Patients: A Systematic Review
Yogamba M Shivakumar, Eshwar Burra, Kamran Shahid, Yonas Tamene, Shefali P Mody, Kaiser O Sadiq, Sai Sri Penumetcha
Cureus  year: 2023  
doi: 10.7759/cureus.45787

25. Kidney dysfunction in adults living with HIV and HBV: a 10-year retrospective cohort study across seven Asia-Pacific countries
Thinh Toan Vu, Dhanushi Rupasinghe, Dung Thi Hoai Nguyen, Jun Yong Choi, Sasisopin Kiertiburanakul, Nagalingeswaran Kumarasamy, Suwimon Khusuwan, Vohith Khol, I Ketut Agus Somia, Man Po Lee, Sanjay Pujari, Anchalee Avihingsanon, Cuong Duy Do, Jeremy Ross, Awachana Jiamsakul
AIDS Research and Therapy  vol: 23  issue: 1  year: 2025  
doi: 10.1186/s12981-025-00831-8

26. A systematic review assessing the association of inflammatory markers with kidney dysfunction in people living with HIV on highly active antiretroviral therapy
Joel Choshi, Sidney Hanser, Sihle E. Mabhida, Haskly Mokoena, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Machoene D Sekgala, Bongani B. Nkambule, Zandile J.R. Mchiza, Duduzile Ndwandwe, Unati Nqebelele, André P. Kengne, Phiwayinkosi V. Dludla
BMC Infectious Diseases  vol: 24  issue: 1  year: 2024  
doi: 10.1186/s12879-024-09594-5

27. Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis Eligibility
Nimish Patel, Jill Blumenthal, Michael P. Dubé, Allison Hood, Robert Bolan, Sheldon Morris
LGBT Health  vol: 9  issue: 3  first page: 199  year: 2022  
doi: 10.1089/lgbt.2021.0219

28. Tubulointerstitial Nephritis: Underdiagnosed Kidney Disease in Person Living with HIV
Afiatin Makmun, Aditya Rangga Fandiarta, Lilik Sukesi, Yovita Hartantri
Open Access Macedonian Journal of Medical Sciences  vol: 11  issue: B  first page: 453  year: 2023  
doi: 10.3889/oamjms.2023.11585

29. A systematic review assessing the potential use of cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy
Sidney Hanser, Joel Choshi, Haskly Mokoena, Sihle E. Mabhida, Zandile J. R. Mchiza, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Bongani B. Nkambule, Duduzile Ndwandwe, Unati Nqebelele, André P. Kengne, Phiwayinkosi V. Dludla
Frontiers in Medicine  vol: 11  year: 2024  
doi: 10.3389/fmed.2024.1295217

30. Pharmacokinetic Feasibility of Stability-Enhanced Solid-State (SESS) Tenofovir Disoproxil Free Base Crystal
Byoung Hoon You, Mingoo Bae, Seung Yon Han, Jieun Jung, Kiwon Jung, Young Hee Choi
Pharmaceutics  vol: 15  issue: 5  first page: 1392  year: 2023  
doi: 10.3390/pharmaceutics15051392

31. A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B
A Young Cho, Ju Hwan Oh, Hee-Chan Moon, Gum Mo Jung, Young Suk Lee, Yeong Jin Choi, In O Sun, Kwang Young Lee
Kidney Research and Clinical Practice  vol: 39  issue: 3  first page: 373  year: 2020  
doi: 10.23876/j.krcp.20.018

32. Decline in estimated glomerular filtration rate following substitution of Nevirapine-based regimen with Tenofovir-based regimen in Indonesia
Evy Yunihastuti, Pringgodigdo Nugroho, Muhammad Yusuf, Salfia Dian Lastari, Fadlika Harinda, Tiara Kumala Putri, Meivina Ramadhani Pane, Metra Adi Pratama, Mira Yulianti, Alvina Widhani, Suzy Maria, Anshari Saifuddin Hasibuan, Maruhum Bonar Hasiholan Marbun, Sukamto Koesnoe, Teguh Harjono Karjadi
BMC Infectious Diseases  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12879-025-11710-y

33. Effectiveness, Weight Changes, and Metabolic Outcomes on Switch to Generic Dolutegravir/Lamivudine Among People with HIV in Western India: An Observational Study
Sanjay Pujari, Sunil Gaikwad, Suhrud Panchawagh, Abhishek Chitalikar, Kedar Joshi, Chaitrangi Rohekar, Diagamber Dabhade, Vivek Bele
AIDS Research and Human Retroviruses  vol: 40  issue: 4  first page: 204  year: 2024  
doi: 10.1089/aid.2022.0167

34. Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014
Supattra Rungmaitree, Linda Aurpibul, Brookie M Best, Xiang Li, Meredith G Warshaw, Hong Wan, Nicole H Tobin, Patricia Jumes, Randi Leavitt, Katie McCarthy, Rachel Scheckter, Pradthana Ounchanum, Avy Violari, Hedy Teppler, Havilland Campbell, Chelsea Krotje, Ellen Townley, Jack Moye, Ann J Melvin, Justine Beck, Thucuma Sise, Bill G Kapogiannis, Kathleen George, Patricia Morgan, Yvonne Woolwine-Cunningham, Rebecca Leblanc, Kathleen Trabert, Jeanne Mendell, Carmelita Alvero, Mona Farhad, Sarah Pasyar, Petronella Muresan, Nehali Patel, Adrienne English, Ryan Heince, Sandra Jones, Ellen Cooper, Debra McLaud, Elizabeth McFarland, Shane Curran Hays, Jennifer Dunn, Kacey Navarro, Amanda Robson, Hilda Ndiwani, Ruth Mathiba, Avy Violari, Nastassja Ramsagar, Nuntisa Chotirosniramit, Chintana Khamrong, Jiraporn Chantong, Angkana Srita, Tim R Cressey, Praornsuda Sukrakanchana, Kanyanee Kaewmamuang, Yupawan Thaweesombat, Nirun Vanprapar, Kulkanya Chokephaibulkit, Nantaka Kongstan, Watcharee Lermankul
Journal of the Pediatric Infectious Diseases Society  vol: 12  issue: 12  first page: 602  year: 2023  
doi: 10.1093/jpids/piad078

35. Tenofovir-Associated Kidney Dysfunction and Bone Fracture: A Case Report and Literature Review
KK Athish, Shobhana Nayak Rao, Venkat H Marimuthu, Vamsi Krishna, Anwadevi Arun
Cureus  year: 2024  
doi: 10.7759/cureus.61562

36. Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men
J. Hutchinson, B. Neesgard, J. Kowalska, K. Grabmeier‐Pfistershammer, M. Johnson, K. Kusejko, S. De Wit, F. Wit, C. Mussini, A. Castagna, M. Stecher, C. Pradier, P. Domingo, C. Carlander, J. Wasmuth, N. Chkhartishvili, V. Uzdaviniene, A. Haberl, A. d'Arminio Monforte, H. Garges, J. Gallant, M. Said, B. Schmied, M. van der Valk, D. Konopnicki, N. Jaschinski, A. Mocroft, L. Greenberg, F. Burns, L. Ryom, K. Petoumenos
HIV Medicine  vol: 25  issue: 9  first page: 1058  year: 2024  
doi: 10.1111/hiv.13662

37. Age-dependent mitochondrial toxicity in renal stem cells: A precise 3D silk matrix model
Pengfei Yu, Huifen Ding, Jian-Xing Ma, Zhongping Duan, Yu Chen, Anthony Atala, Yuanyuan Zhang
Genes & Diseases  first page: 102108  year: 2026  
doi: 10.1016/j.gendis.2026.102108

38. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
Maya M. Mellor, Anne C. Bast, Nicholas R. Jones, Nia W. Roberts, José M. Ordóñez-Mena, Alastair J.M. Reith, Christopher C. Butler, Philippa C. Matthews, Jienchi Dorward
AIDS  vol: 35  issue: 4  first page: F1  year: 2021  
doi: 10.1097/QAD.0000000000002836

39. Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia
Sayali B. Thakare, Tukaram E. Jamale, Saba S. Memon
Best Practice & Research Clinical Endocrinology & Metabolism  vol: 38  issue: 2  first page: 101839  year: 2024  
doi: 10.1016/j.beem.2023.101839

40. Low-dose quercetin at 25 mg/kg ameliorates dolutegravir-lamivudine-tenofovirdisoproxilfumarate-inducedcardio-hepato-renal toxicities in Wistar rats
Innocent A. Edagha, Blessing C. Akpan, David O. Edem, Moses A. Ataben, Blessing U. Bassey, Royal S. Itama, Deborah C. Evogor
Clinical Phytoscience  vol: 10  issue: 1  year: 2024  
doi: 10.1186/s40816-024-00377-8

41. Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study
Larissa D. L. N. Costa, Uiara S. Lima, Vandilson Rodrigues, Mayara I. S. Lima, Lucilene A. Silva, Jorim Ithamar, Conceição M. P. S. Azevedo
BMC Infectious Diseases  vol: 23  issue: 1  year: 2023  
doi: 10.1186/s12879-023-08009-1

42. The evaluation of an HIV-PrEP drug on the vascular health outcomes in a diet-induced prediabetes condition rat model
Khanyisa Maswanganyi, Amogelang Sedibe, Andile Khathi, Mlindeli Gamede
Scientific Reports  year: 2026  
doi: 10.1038/s41598-026-46956-2

43. Determinants of Risk Factors for Renal Impairment among HIV‐Infected Patients Treated with Tenofovir Disoproxil Fumarate‐Based Antiretroviral Regimen in Southern Vietnam
Cuong Q Hoang, Hai D Nguyen, Huy Q Vu, Khai T Nguyen, Linh T Hoang, Hong Ly, Thang D Tat, Lan T Phan, Josep-Maria Llibre
BioMed Research International  vol: 2020  issue: 1  year: 2020  
doi: 10.1155/2020/7650104

44. Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) Trial
Tapiwa G. Mbengeranwa, Lauren Ziemba, Sean S. Brummel, Ben Johnston, Haseena Cassim, Gerhard Theron, Zukiswa Ngqawana, Deo Wabwire, Katie McCarthy, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda
JAIDS Journal of Acquired Immune Deficiency Syndromes  vol: 99  issue: 2  first page: 211  year: 2025  
doi: 10.1097/QAI.0000000000003656